GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
We read with interest the recent letter by Ramiro et al 1 reporting data from a systematic literature review on the measurement of enthesitis, dactylitis and nail disease in psoriatic arthritis (PsA) clinical trials. The authors highlight the great variety in the outcome measures chosen, cut points...
Автори: | Tillett, W, Orbai, A, Ogdie, A, Leung, Y, Strand, V, Gladman, D, Mease, P, Coates, L |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
BMJ Publishing Group
2017
|
Схожі ресурси
Схожі ресурси
-
Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group
за авторством: Leung, Y-Y, та інші
Опубліковано: (2023) -
Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative
за авторством: Antony, A, та інші
Опубліковано: (2021) -
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set
за авторством: Leung, Y, та інші
Опубліковано: (2019) -
The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates
за авторством: Leung, YY, та інші
Опубліковано: (2020) -
Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
за авторством: Orbai, A-M, та інші
Опубліковано: (2019)